In May, Ed Patrick, a British anesthesiologist, received distressing news from the hospital regarding his mother, Ann, who was gravely ill. Having battled Parkinson's disease for several years, she was suffering from persistent seizures that proved resistant to her anti-seizure medications. Upon arriving at the hospital, Patrick found his mother unconscious and showing signs of kidney failure.
Determined to help, he utilized Gemini, an artificial intelligence tool, to research and summarize pertinent medical studies related to her symptoms. This investigation led him to consider a possible vitamin B6 deficiency, which he suspected might be linked to the medications Ann had been prescribed for her Parkinson's condition.
Patrick presented this theory to her medical team, resulting in Ann receiving intravenous vitamin B6. Neurologist Bruno Gran remarked on the unexpected rapidity and effectiveness of the treatment, stating, "Within minutes of administering vitamin B6, Ann's seizure activity stopped." Since that intervention, Ann has remained seizure-free, and her cognitive abilities appear to have improved significantly, resembling those of five to ten years ago.
Remarkably, only 14 similar cases have been reported in medical literature. Patrick is now advocating for further research to explore whether vitamin B6 could provide benefits for others diagnosed with Parkinson's, not just in acute situations like his mother's but also in addressing the gradual cognitive decline associated with the disease. Medical professionals indicate that clinical trials would be essential before this treatment could be implemented on a broader scale.
Informational material. 18+.
